More uses of breast cancer drug Palbociclib discovered

Palbociclib - a breast cancer treatment drug that can effectively treat other diseases. This is the result of a study recently announced by the Abramson Cancer Center (ACC) of the University of Pennsylvania (USA).

Illustration photo. (amazonaws.com)

In an article published in the journal JAMA Oncology, ACC researchers said the drug Palbociclib can kill cancer cells without significantly affecting other healthy cells.

According to experts, this drug also has the ability to effectively treat rare diseases that often occur in children such as lymphoma, tumors and teratoma.

In a phase 1 trial, palbociclib was given to 17 patients with mantle cell lymphoma. Results showed that one patient had a “complete response,” meaning the cancer was gone for a period of time, while two other patients had “partial responses.”

In addition, research also shows that the drug Palbociclib has the ability to prolong the life of patients.

Palbociclib is the first drug in the CDK4/6 inhibitor class. It is the first drug approved for the treatment of breast cancer./.

According to VIETNAM+